Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 2:58 pm Purchase | 2023-12-31 | 13G | Talphera, Inc. TLPH | Armistice Capital, LLC | 890,346 4.990% | 26,018 (+3.01%) | Filing History |
| 2024-02-13 8:00 pm Sale | 2023-12-31 | 13G | Talphera, Inc. TLPH | Lind Global Fund II LP | 735,296 4.200% | -367,648 (-33.33%) | Filing |
| 2024-01-22 6:46 pm Purchase | 2024-01-17 | 13D | Talphera, Inc. TLPH | Nantahala Capital Management, LLC | 1,992,519 11.800% | 1,992,519 (New Position) | Filing History |
| 2023-07-31 7:50 pm Purchase | 2023-07-20 | 13G | Talphera, Inc. TLPH | Lind Global Fund II LP | 1,102,944 6.500% | 1,102,944 (New Position) | Filing History |
| 2023-02-14 11:50 am Purchase | 2022-12-31 | 13G | Talphera, Inc. TLPH | Armistice Capital, LLC | 864,328 9.990% | 864,328 (New Position) | Filing History |
| 2022-02-14 6:43 pm Purchase | 2021-12-31 | 13G | AcelRx Pharmaceuticals, Inc. ACRX | Armistice Capital, LLC | 615,724 9.990% | 615,724 (New Position) | Filing History |
| 2022-01-27 2:51 pm Sale | 2022-01-27 | 13G | AcelRx Pharmaceuticals, Inc. ACRX | BML Investment Partners, L.P. | 0 0.000% | -297,800 (Position Closed) | Filing History |
| 2021-07-12 08:29 am Sale | 2021-06-30 | 13G | AcelRx Pharmaceuticals, Inc. ACRX | BlackRock Inc. BLK | 113,302 1.900% | -168,745 (-59.83%) | Filing History |
| 2021-02-10 2:58 pm Purchase | 2021-02-10 | 13G | AcelRx Pharmaceuticals, Inc. ACRX | BML Investment Partners, L.P. | 297,800 6.000% | 59,910 (+25.18%) | Filing History |
| 2021-01-28 5:55 pm Purchase | 2020-12-31 | 13G | AcelRx Pharmaceuticals, Inc. ACRX | BlackRock Inc. BLK | 282,047 5.700% | 1,446 (+0.52%) | Filing History |
| 2020-10-27 4:04 pm Unchanged | 2020-10-09 | 13G | AcelRx Pharmaceuticals, Inc. ACRX | BML Investment Partners, L.P. | 237,890 5.300% | 0 (Unchanged) | Filing History |
| 2020-10-27 3:50 pm Purchase | 2020-10-09 | 13G | AcelRx Pharmaceuticals, Inc. ACRX | BML Investment Partners, L.P. | 237,890 5.300% | 237,890 (New Position) | Filing History |